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Kynurenine pathway (KP), the quantitatively main branch
of tryptophan metabolism, has long been considered a
source of nicotinamide adenine dinucleotide, although
several of its products, the so-called kynurenines, are
endowed with the capacity to activate glutamate recep-
tors, thus potentially influencing a large group of func-
tions in the central nervous system (CNS). In fact,
Kynurenic Acid and Quinolinic Acid are able to interact
with ionotropic glutamate receptors and Cinnabarinic
Acid has been reported as an orthosteric agonist of meta-
botropic glutamate receptors (mGlu4), and Xanthurenic
Acid has been recently demonstrated to be a putative
agonist of metabotropic glutamate receptors 2/3 (mGlu2/
3). Moreover, 3-HK and 3-HANA have mainly been stu-
died, since they have been shown to induce neurotoxic
effects by increasing oxidative stress and the production
of free radicals or through excitotoxicity. Migraine has a
complex pathophysiology in which both central and per-
ipheral components of the trigeminal pain pathway play a
central role. The trigemino-vascular activation during the
attack has largely been described, and recently the brain-
stem nuclei, called “migraine generators”, have been
reported to be involved in migraine. Moreover, a series of
destabilizing events within the brain trigger a cortical
spreading depression (CSD), responsible for the aura
phenomena and for trigeminal activation. The role of
glutamate is heavily supported both in the trigemino-vas-
cular as well as in brainstem nuclei activation, and
furthermore in the CSD initiation and propagation. Some
of the KP metabolites able to interact both with ionotro-
pic and metabotropic glutamate receptors might be
involved in migraine pathophysiology. Despite the large
number of studies conducted on migraine etiopathology,
the KP has only been recently linked to this disease.
Nonetheless, some evidence suggests an intriguing role
for some kynurenines, and an exploratory study on the
serum kynurenine levels has been helpful to better
understand possible alterations of the kynurenine path-
way in patients suffering from migraine.
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